Promis Neurosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that Gail Farfel, Ph.D., Chief Executive Officer, will present at the upcoming Oppenheimer 33rd Annual Conference on Monday, March 13, 2023 at 12:30 p.m. ET.

 

The webcasted presentation will be available on ProMIS’ website at www.promisneurosciences.com/news-media/events, and will be available for at least 30 days following the event.

 

ProMIS Neurosciences Inc. is a development stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). The Company’s proprietary target discovery engine is based on the use of two complementary techniques. The Company applies its thermodynamic, computational discovery platform – ProMIS™ and Collective Coordinates – to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. ProMIS has offices in Toronto, Ontario and Cambridge, Massachusetts. ProMIS is listed on Nasdaq and the Toronto Stock Exchange under the symbol PMN.

 

www.promisneurosciences.com

Hot this week

Fintech Visionaries Brett King & Chris Skinner Unite at WebAccountPlus AI Innovation Ltd

WebAccountPlus AI Innovation Ltd., the groundbreaking Swiss fintech firm...

EUROPE’S PUBLISHERS WELCOME EUROPEAN COMMISSION ACTION AGAINST APPLE APP STORE FOR BREACH OF DIGITAL MARKETS ACT

The European Publishers Council (EPC) welcomes the European Commission’s...

A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States

Virtue Recovery Center in Las Vegas, NV, is stepping...

A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States

Virtue Recovery Center in Las Vegas, NV, is stepping...

“A Final Solution to Gaza”: Norman Finkelstein on Israel’s War and Western Complicity

In a searing and unflinching conversation with journalist Chris...

Topics

Fintech Visionaries Brett King & Chris Skinner Unite at WebAccountPlus AI Innovation Ltd

WebAccountPlus AI Innovation Ltd., the groundbreaking Swiss fintech firm...

EUROPE’S PUBLISHERS WELCOME EUROPEAN COMMISSION ACTION AGAINST APPLE APP STORE FOR BREACH OF DIGITAL MARKETS ACT

The European Publishers Council (EPC) welcomes the European Commission’s...

“A Final Solution to Gaza”: Norman Finkelstein on Israel’s War and Western Complicity

In a searing and unflinching conversation with journalist Chris...

CARDIEUX Shocks Shoppers with a Never-Before-Seen 95% Off Luxury Jewelry Code

What started as a rumor is now confirmed—CARDIEUX’s 95%...

Fexco Launches Cross-Industry Payment Orchestration Platform Building on Cruise Market Dominance

Fexco, the Irish-based financial services and fintech company, has...

Former Israeli Pilot Calls for Accountability Over Gaza Strikes

Yonatan Shapira, a former Israeli Air Force (IAF) rescue...

Related Articles

Popular Categories

spot_imgspot_img